Hisun Pharma to Invest $162 Million into its JV with Pfizer

More information surfaced about the financing of the high-profile JV being set up by Zhejiang Hisun Pharma and Pfizer. Hisun will contribute a total of $162.5 million for a 51% stake, implying a value of $318.6 million for the venture. The registered capital, however, is listed as $250 million. Hisun may have put in extra capital to nail down a majority stake, but it probably didn’t offer up an extra $70 million for control. More details... Stock Symbols: (SHA: 600267) (NYSE: PFE) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});